We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

By LabMedica International staff writers
Posted on 01 Oct 2024

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. More...

Antigen-based tests provide quicker results but often lack the sensitivity and accuracy of PCR. Now, a new method that combines confocal fluorescence microscopy with microfluidic laminar flow marks a significant advancement in virus detection. Unlike traditional PCR, this innovative approach can rapidly detect individual virus particles cost-effectively, using a 3D-printed microscopy technology called Brick-MIC. This method boosts both sensitivity and specificity in virus detection, potentially transforming how viral outbreaks are monitored and managed. Its portable and user-friendly design makes it well-suited for wider clinical applications, strengthening public health responses to emerging viral challenges.

The breakthrough virus detection method developed by a group of researchers that included scientists from The Hebrew University of Jerusalem (Rehovot, Israel) uses laminar flow in a microfluidic channel along with fluorescence signals from free dyes and labeled antibodies to reveal key characteristics of nanoparticles. The team demonstrated the method's accuracy by testing it on fluorescent beads and various viruses, including the SARS-CoV-2 Spike protein. One of the key elements of this new assay is the use of hydrodynamic focusing, which significantly enhances sensitivity, enabling virus detection at clinically relevant concentrations.

Its portability and the use of the affordable 3D-printed Brick-MIC setup make it accessible for clinical environments. This innovation signals a shift toward rapid and precise virus detection, in line with personalized healthcare principles. By enabling fast, specific identification of viruses, this technology could help tailor medical interventions to individual patient needs, improving the timeliness and effectiveness of treatments. The research was published in iScience, with the 3D-printed microscopy approach detailed in Science Advances.


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.